IPO - REGENXBIO Inc.

Form Type: S-3

Filing Date: 2025-06-13

Corporate Action: Ipo

Type: New

Accession Number: 000119312525140870

Filing Summary: REGENXBIO Inc. filed a registration statement on Form S-3 with the SEC for the resale of up to 268,096 shares of its common stock by a selling stockholder. These shares are issuable upon exercise of a warrant at an exercise price of $14.92, from a private placement linked to a Loan Agreement dated May 16, 2025. The company anticipates receiving up to $4.0 million from the warrant exercise if fully executed. The common stock is listed on the Nasdaq Global Select Market under the symbol 'RGNX'. The document highlights the risks associated with the investment, which should be carefully understood by potential buyers. The company outlines that it will not receive any proceeds from the sale of these shares by the selling stockholder, while explaining the important legal frameworks governing such transactions, including the Delaware Business Combination Statute that restricts transactions with interested stockholders.